Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume -, Issue -, Pages 1-23
Publisher
Informa UK Limited
Online
2020-02-19
DOI
10.1080/17425247.2020.1729119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil
- (2019) Ali Keshavarz et al. MOLECULAR PHARMACEUTICS
- Phenotypically-Silent Bone Morphogenetic Protein Receptor 2 ( Bmpr2 ) Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing The Risk for Neointimal Transformation
- (2019) Wen Tian et al. CIRCULATION
- Fabrication and evaluation of nanofibrous polyhydroxybutyrate valerate scaffolds containing hydroxyapatite particles for bone tissue engineering
- (2018) Behnam Noorani et al. International Journal of Polymeric Materials and Polymeric Biomaterials
- Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH
- (2018) Jahidur Rashid et al. JOURNAL OF CONTROLLED RELEASE
- Cerivastatin Nanoliposome as a Potential Disease Modifying Approach for the Treatment of Pulmonary Arterial Hypertension
- (2018) Young Lee et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery
- (2018) Jahidur Rashid et al. MOLECULAR PHARMACEUTICS
- Fabrication and evaluation of nanofibrous polyhydroxybutyrate valerate scaffolds containing hydroxyapatite particles for bone tissue engineering
- (2018) Behnam Noorani et al. International Journal of Polymeric Materials and Polymeric Biomaterials
- Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling
- (2018) Jahidur Rashid et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension
- (2017) David Kylhammar et al. EUROPEAN HEART JOURNAL
- Effects of long-term iloprost treatment on right ventricular function in patients with Eisenmenger syndrome
- (2017) Min Ku Chon et al. Journal of Cardiology
- Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH)
- (2017) Jahidur Rashid et al. JOURNAL OF CONTROLLED RELEASE
- Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency
- (2017) Nilesh Gupta et al. MOLECULAR PHARMACEUTICS
- Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions
- (2017) Jacob S. Brenner et al. Nanomedicine-Nanotechnology Biology and Medicine
- Physical Activity and Symptoms in Pulmonary Arterial Hypertension
- (2016) Lea Ann Matura et al. CHEST
- Intratracheal Administration of Prostacyclin Analogue–incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension
- (2016) Satoshi Akagi et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge
- (2016) Tamara Roldan et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid
- (2016) Abhinav Kumar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Formulation and process considerations for the design of sildenafil-loaded polymeric microparticles by vibrational spray-drying
- (2016) Moritz Beck-Broichsitter et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH
- (2016) Kamrun Nahar et al. PHARMACEUTICAL RESEARCH
- A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension
- (2016) Nura A. Mohamed et al. Journal of Cardiovascular Translational Research
- Liposome size and charge optimization for intraarterial delivery to gliomas
- (2016) Shailendra Joshi et al. Drug Delivery and Translational Research
- Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era
- (2016) Bradley A. Maron et al. JAMA Cardiology
- New Developments in Liposomal Drug Delivery
- (2015) Bhushan S. Pattni et al. CHEMICAL REVIEWS
- Acute Effects of Rho-Kinase Inhibitor Fasudil on Pulmonary Arterial Hypertension in Patients With Congenital Heart Defects
- (2015) Jia-wang Xiao et al. CIRCULATION JOURNAL
- Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)
- (2015) Lewis J. Rubin et al. EUROPEAN RESPIRATORY JOURNAL
- Delivery of Imatinib-Incorporated Nanoparticles into Lungs Suppresses the Development of Monocrotaline-Induced Pulmonary Arterial Hypertension
- (2015) Satoshi Akagi et al. International Heart Journal
- Inhalable liposomal dry powder of gemcitabine-HCl: Formulation, in vitro characterization and in vivo studies
- (2015) Manit Gandhi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeted endothelial nanomedicine for common acute pathological conditions
- (2015) Vladimir V. Shuvaev et al. JOURNAL OF CONTROLLED RELEASE
- Management of Pulmonary Arterial Hypertension
- (2015) Vallerie V. McLaughlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin
- (2015) Fernanda Andrade et al. Nanomedicine-Nanotechnology Biology and Medicine
- The molecular targets of approved treatments for pulmonary arterial hypertension
- (2015) Marc Humbert et al. THORAX
- Prostanoid therapies in the management of pulmonary arterial hypertension
- (2015) Barbara LeVarge Therapeutics and Clinical Risk Management
- Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
- (2015) A Dasgupta et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Novel Vascular Homing Peptide Strategy to Selectively Enhance Pulmonary Drug Efficacy in Pulmonary Arterial Hypertension
- (2014) Michie Toba et al. AMERICAN JOURNAL OF PATHOLOGY
- Nanocarriers for Vascular Delivery of Anti-Inflammatory Agents
- (2014) Melissa D. Howard et al. Annual Review of Pharmacology and Toxicology
- Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults
- (2014) Darren B. Taichman et al. CHEST
- Pulmonary Arterial Hypertension
- (2014) Yen-Chun Lai et al. CIRCULATION RESEARCH
- Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment
- (2014) Tianshi Feng et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Cell permeable peptide conjugated nanoerythrosomes of fasudil prolong pulmonary arterial vasodilation in PAH rats
- (2014) Nilesh Gupta et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Development and in vivo evaluation of papain-functionalized nanoparticles
- (2014) Christiane Müller et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Acute hemodynamic response of infused fasudil in patients with pulmonary arterial hypertension: A randomized, controlled, crossover study
- (2014) Xin Jiang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
- (2014) Mukta Paranjpe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
- (2014) Pritesh Jain et al. International Journal of Nanomedicine
- Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature
- (2014) Kamrun Nahar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation
- (2014) Melissa D. Howard et al. JOURNAL OF CONTROLLED RELEASE
- Optimization of drug loading to improve physical stability of paclitaxel-loaded long-circulating liposomes
- (2014) Vinayagam Kannan et al. JOURNAL OF LIPOSOME RESEARCH
- Peptide–Micelle Hybrids Containing Fasudil for Targeted Delivery to the Pulmonary Arteries and Arterioles to Treat Pulmonary Arterial Hypertension
- (2014) Nilesh Gupta et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Peptide-Coated Liposomal Fasudil Enhances Site Specific Vasodilation in Pulmonary Arterial Hypertension
- (2014) Kamrun Nahar et al. MOLECULAR PHARMACEUTICS
- Nano-Engineered Erythrocyte Ghosts as Inhalational Carriers for Delivery of Fasudil: Preparation and Characterization
- (2014) Nilesh Gupta et al. PHARMACEUTICAL RESEARCH
- Multifunctional polymeric micelles for delivery of drugs and siRNA
- (2014) Aditi M. Jhaveri et al. Frontiers in Pharmacology
- Comparison of Acute Hemodynamic Effects of Inhaled Nitric Oxide and Inhaled Epoprostenol in Patients with Pulmonary Hypertension
- (2014) Ioana R. Preston et al. Pulmonary Circulation
- Safety and Efficacy of Transition from Inhaled Treprostinil to Parenteral Treprostinil in Selected Patients with Pulmonary Arterial Hypertension
- (2014) Ioana R. Preston et al. Pulmonary Circulation
- Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
- (2013) Marius M. Hoeper et al. CIRCULATION
- Parenteral and Inhaled Prostanoid Therapy in the Treatment of Pulmonary Arterial Hypertension
- (2013) Vallerie V. McLaughlin et al. CLINICS IN CHEST MEDICINE
- VE-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity
- (2013) Monica Giannotta et al. DEVELOPMENTAL CELL
- Development of chitosan-based dry powder inhalation system of cisplatin for lung cancer
- (2013) MalaD Menon et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Sirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: A comparison of phospholipid micelles and liposomes
- (2013) Azadeh Haeri et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
- (2013) Vivek Gupta et al. JOURNAL OF CONTROLLED RELEASE
- Aerosol generation using nanometer liposome suspensions for pulmonary drug delivery applications
- (2013) Saptarshi Chattopadhyay JOURNAL OF LIPOSOME RESEARCH
- Updated Clinical Classification of Pulmonary Hypertension
- (2013) Gerald Simonneau et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhaled PLGA Particles of Prostaglandin E1 Ameliorate Symptoms and Progression of Pulmonary Hypertension at a Reduced Dosing Frequency
- (2013) Vivek Gupta et al. MOLECULAR PHARMACEUTICS
- Riociguat for the Treatment of Pulmonary Arterial Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tyrosine Kinase Inhibitors in Pulmonary Arterial Hypertension: A Double-Edge Sword?
- (2013) Laurent Godinas et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection
- (2013) J P Clancy et al. THORAX
- Targeted Antiscarring Therapy for Tissue Injuries
- (2013) Tero A.H. Järvinen et al. Advances in Wound Care
- Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery
- (2012) Laura M. Ensign et al. ADVANCED MATERIALS
- Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension
- (2012) Yi Ling et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Depósito pulmonar de partículas inhaladas
- (2012) Ana Fernández Tena et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Inflammation in Pulmonary Arterial Hypertension
- (2012) Laura C. Price et al. CHEST
- Assessment of Pulmonary Artery Morphology by Optical Coherence Tomography
- (2012) Ning Li et al. Heart Lung and Circulation
- PEG–PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin
- (2012) Brijeshkumar Patel et al. JOURNAL OF CONTROLLED RELEASE
- PLGA-based nanoparticles: An overview of biomedical applications
- (2012) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- In Vitro and In Vivo Characterisation of PEG-Lipid-Based Micellar Complexes of Salmon Calcitonin for Pulmonary Delivery
- (2012) Leonie Baginski et al. PHARMACEUTICAL RESEARCH
- Slow Receptor Dissociation Kinetics Differentiate Macitentan from Other Endothelin Receptor Antagonists in Pulmonary Arterial Smooth Muscle Cells
- (2012) John Gatfield et al. PLoS One
- Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension
- (2011) Takeo Urakami et al. AMERICAN JOURNAL OF PATHOLOGY
- Biodegradable Nanoparticles Composed Entirely of Safe Materials that Rapidly Penetrate Human Mucus
- (2011) Ming Yang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension
- (2011) Lewis J. Rubin et al. CHEST
- Paclitaxel loaded PEG5000–DSPE micelles as pulmonary delivery platform: Formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation
- (2011) Kanwaldeep K. Gill et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension
- (2011) Dermot S O'Callaghan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Nanoparticle-Mediated Delivery of Pitavastatin Into Lungs Ameliorates the Development and Induces Regression of Monocrotaline-Induced Pulmonary Artery Hypertension
- (2011) Ling Chen et al. HYPERTENSION
- Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations
- (2011) Mohanad Sahib et al. International Journal of Nanomedicine
- Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
- (2011) Rassoul Dinarvand et al. International Journal of Nanomedicine
- Influence of PEI as a core modifying agent on PLGA microspheres of PGE1, a pulmonary selective vasodilator
- (2011) Vivek Gupta et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Disruption of PPARγ/β-catenin–mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival
- (2011) Tero-Pekka Alastalo et al. JOURNAL OF CLINICAL INVESTIGATION
- Nanocarriers for vascular delivery of antioxidants
- (2011) Elizabeth Hood et al. Nanomedicine
- Polymyxin B self-associated with phospholipid nanomicelles
- (2011) Kenneth S. Brandenburg et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- PLGA Microparticles Encapsulating Prostaglandin E1-Hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) Complex for the Treatment of Pulmonary Arterial Hypertension (PAH)
- (2011) Vivek Gupta et al. PHARMACEUTICAL RESEARCH
- Heparan Sulfate Proteoglycans
- (2011) S. Sarrazin et al. Cold Spring Harbor Perspectives in Biology
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- REVIEW: Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: An Overview
- (2010) Shahzad G. Raja Cardiovascular Therapeutics
- The Particle has Landed—Characterizing the Fate of Inhaled Pharmaceuticals
- (2010) John S. Patton et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
- (2010) Vallerie V. McLaughlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lung Vascular Targeting Using Antibody to Aminopeptidase P: CT-SPECT Imaging, Biodistribution and Pharmacokinetic Analysis
- (2010) A. Chrastina et al. JOURNAL OF VASCULAR RESEARCH
- Nanomicellar formulations for sustained drug delivery: strategies and underlying principles
- (2010) Ruchit Trivedi et al. Nanomedicine
- Inhaled Epoprostenol for the Treatment of Pulmonary Arterial Hypertension in Critically Ill Adults
- (2010) Mitchell S Buckley et al. PHARMACOTHERAPY
- PPARγ as a potential therapeutic target in pulmonary hypertension
- (2010) Roy L. Sutliff et al. Therapeutic Advances in Respiratory Disease
- RhoA and Rho Kinase Activation in Human Pulmonary Hypertension
- (2009) Christophe Guilluy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
- (2009) et al. CIRCULATION
- Evidence for Rho-Kinase Activation in Patients With Pulmonary Arterial Hypertension
- (2009) Zhulanqiqige Do.e et al. CIRCULATION JOURNAL
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
- (2009) et al. EUROPEAN HEART JOURNAL
- Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension
- (2009) Ronald J. Oudiz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Nitric Oxide-Loaded Echogenic Liposomes for Nitric Oxide Delivery and Inhibition of Intimal Hyperplasia
- (2009) Shao-Ling Huang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diagnosis and Assessment of Pulmonary Arterial Hypertension
- (2009) David B. Badesch et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intratracheal Gene Transfer of Adrenomedullin Using Polyplex Nanomicelles Attenuates Monocrotaline-induced Pulmonary Hypertension in Rats
- (2009) Mariko Harada-Shiba et al. MOLECULAR THERAPY
- Inhalation of endothelin receptor blockers in pulmonary hypertension
- (2008) Hanno H. Leuchte et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles that “Slip” through the Human Mucus Barrier
- (2008) Ying-Ying Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities
- (2008) Michael D. McGoon et al. CHEST
- Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
- (2008) Nazzareno Galiè et al. CIRCULATION
- Prostacyclin therapies for the treatment of pulmonary arterial hypertension
- (2008) M. Gomberg-Maitland et al. EUROPEAN RESPIRATORY JOURNAL
- Inhalation of vasoactive intestinal peptide in pulmonary hypertension
- (2008) H. H. Leuchte et al. EUROPEAN RESPIRATORY JOURNAL
- Endothelin receptor antagonists in pulmonary arterial hypertension
- (2008) J. Dupuis et al. EUROPEAN RESPIRATORY JOURNAL
- Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension
- (2008) R. T. Schermuly et al. EUROPEAN RESPIRATORY JOURNAL
- Multifunctional Micellar Nanomedicine for Cancer Therapy
- (2008) Elvin Blanco et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Bloodstream Infections in Patients Given Treatment With Intravenous Prostanoids
- (2008) Alexander J. Kallen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Inhaled nanoparticles—A current review
- (2008) Wei Yang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles
- (2008) Karin Wernig et al. JOURNAL OF CONTROLLED RELEASE
- From fluorescence nanoscopy to nanoscopic medicine
- (2008) Reiner Peters Nanomedicine
- Shape Induced Inhibition of Phagocytosis of Polymer Particles
- (2008) Julie A. Champion et al. PHARMACEUTICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now